Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial (Q41466790)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 February 2015

Language	Label	Description	Also known as
English	Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial	scientific article published on 4 February 2015

Statements

scholarly article

1 reference

Europe PubMed Central

1 October 2017

Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial (English)

1 reference

Europe PubMed Central

1 October 2017

1 reference

based on heuristic

inferred from title

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

9

0 references

author name string

Dick de Zeeuw

1

1 reference

Europe PubMed Central

1 October 2017

Deborah A Anzalone

2

1 reference

Europe PubMed Central

1 October 2017

Valerie A Cain

3

1 reference

Europe PubMed Central

1 October 2017

Michael D Cressman

4

1 reference

Europe PubMed Central

1 October 2017

Hiddo J Lambers Heerspink

5

1 reference

Europe PubMed Central

1 October 2017

Bruce A Molitoris

6

1 reference

Europe PubMed Central

1 October 2017

John T Monyak

7

1 reference

Europe PubMed Central

1 October 2017

Hans-Henrik Parving

8

1 reference

Europe PubMed Central

1 October 2017

James R Sowers

10

1 reference

Europe PubMed Central

1 October 2017

Donald G Vidt

11

1 reference

Europe PubMed Central

1 October 2017

publication date

4 February 2015

1 reference

Europe PubMed Central

1 October 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

1 October 2017

3

1 reference

Europe PubMed Central

1 October 2017

3

1 reference

Europe PubMed Central

1 October 2017

181-190

1 reference

Europe PubMed Central

1 October 2017

Trends in the incidence of treated end-stage renal failure in The Netherlands: hope for the future?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitors and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lowering LDL cholesterol on progression of kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of atorvastatin and rosuvastatin on renal function: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on serum uric acid by difference of the renal protective effects with atorvastatin and rosuvastatin in chronic kidney disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of rosuvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosuvastatin-induced arrest in progression of renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety of rosuvastatin: effects on renal and hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evalu

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical role of urinary low molecular weight proteins: their diagnostic and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970246-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(14)70246-3

1 reference

Europe PubMed Central

1 October 2017

1 reference

Europe PubMed Central

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41466790&oldid=1922007071"